TUESDAY, May 13 (HealthDay News) -- Even though black and white rectal cancer patients have similar referral rates to oncologists, blacks are less likely to receive chemotherapy or radiation therapy, new research shows.

By Steven Reinberg
EmpowHer's HealthDay Reporter

TUESDAY, April 15 (HealthDay News) -- Adding the cancer drug Avastin to radiation and chemotherapy improves results for patients with rectal cancer.

And adding the contraceptive drug mifepristone (RU-486, the so-called abortion pill) to chemotherapy kills ovarian cancer cells that escaped cisplatin treatment.

Those are the conclusions of two reports on new trends in cancer drugs presented Tuesday at the American Association for Cancer Research annual meeting, in San Diego.